drugset
drugset / Trial / NCT04291846

A Food Effect Study of SHR1459 on Healthy Chinese Adult Subjects

NCT04291846 ↗

Phase 1 Completed 28 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedCrossoverOpen-labelBasic science

Summary

The primary objective of the study is to evaluate the effect of high-fat diet on pharmacokinetics of healthy Chinese adult subjects after oral administration of SHR1459 tablets. The secondary objective of the study is to evaluate the safety of single dose of SHR1459 orally in healthy subjects.

Timeline

Start
2020-05-24
Primary completion
2020-06-03
Completion
2020-06-29

Drugs

EvaluationDrugModalityDoseRoute
Subject EDRALBRUTINIB Small molecule — Oral

Indications

No indication recorded.